Screener
Veracyte VCYT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Investing activities | ||
| Purchase of short-term investments | (124,999) | (49,999) |
| Purchases of property, plant and equipment | (2,962) | (1,819) |
| Net cash used in investing activities | (127,961) | (51,818) |
| Financing activities | ||
| Payment of taxes on vested restricted stock units | (9,364) | (9,451) |
| Proceeds from the exercise of common stock options and employee stock purchases | 2,735 | 2,967 |
| Net cash used in financing activities | (6,629) | (6,484) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's investing cash flow?
- Veracyte (VCYT) reported investing cash flow of -$127.96M in Q1 2026.
- How has Veracyte's investing cash flow changed year-over-year?
- Veracyte's investing cash flow decreased by 146.9% year-over-year, from -$51.82M to -$127.96M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Veracyte's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude